RT Journal Article
SR Electronic
T1 G6PD Deficiency Overrepresented Among Pediatric COVID-19 Cases in One Saudi Children Hospital
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.08.20148700
DO 10.1101/2020.07.08.20148700
A1 Al-Aamri, Maryam
A1 Al-Khalifa, Fatima
A1 Al-Nahwi, Fawatim
A1 Al-Ameer, Heba
A1 Al-Abdi, Sameer
YR 2020
UL http://medrxiv.org/content/early/2020/07/13/2020.07.08.20148700.abstract
AB Fluorescent spot test for glucose-6-phosphate dehydrogenase (G6PD) deficiency was performed in 5 boys and 14 girls who had confirmed COVID-19. Out of those, 4 (80%) boys and 5 (36%) girls were found to be G6PD deficient.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We retrospectively reviewed the charts of these children after the approval of the institutional review board of the hospital with a consent waiver.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request.